Is DTx ready for a comeback? Earlier this month, the Centers for Medicare and Medicaid Services (CMS) fee schedule called for reimbursement of digital therapeutics. In February of this year, Happify Health, which became Twill, was acquired by Dario Health. Then, in April, Curio won FDA approval for its postpartum depression digital therapeutic, and for Otsuka’s digital treatment for depression. Perhaps no industry went from “hero to zero and possibly back to hero…” in the post-Covid world faster than the digital therapeutics industry.An industry plagued by claims of poor outcomes and faulty data has seen a renaissance in 2024. In the next two episodes, Brendon Kelly and Dr. Zucker (a long-time veteran and advocate of the DTX space) walk us through the state of the union for digital therapeutics. 

Ver todos los episodios